Filgrastim

Common brands: Neupogen, Releuko, Cyclophosphamide, Frindovyx, Maxidex

Top reporter: Amgen, Inc

Leukocyte Growth Factor [EPC]Corticosteroid [EPC]Alkylating Drug [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Nucleoside Metabolic Inhibitor [EPC]
36,944
Total Reports
18,259
Serious Reports
8,360
Death Reports
30
Reported Reactions
Death Report Ratio: High (22.63%)

Patient Demographics

Male
14,518
Female
16,020

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Filgrastim.

# Reaction Reports % of Total
1 FEBRILE NEUTROPENIA 4,442
9.3%
2 NEUTROPENIA 3,484
7.3%
3 OFF LABEL USE 3,105
6.5%
4 PYREXIA 2,863
6.0%
5 DEATH 2,264
4.8%
6 DIARRHOEA 2,251
4.7%
7 NAUSEA 2,036
4.3%
8 THROMBOCYTOPENIA 1,978
4.2%
9 PNEUMONIA 1,888
4.0%
10 FATIGUE 1,825
3.8%
11 ANAEMIA 1,786
3.8%
12 SEPSIS 1,494
3.1%
13 VOMITING 1,466
3.1%
14 WHITE BLOOD CELL COUNT DECREASED 1,424
3.0%
15 PANCYTOPENIA 1,326
2.8%
16 DYSPNOEA 1,230
2.6%
17 DRUG INEFFECTIVE 1,154
2.4%
18 BONE PAIN 1,076
2.3%
19 PLATELET COUNT DECREASED 1,068
2.2%
20 ASTHENIA 1,064
2.2%
21 INFECTION 1,040
2.2%
22 DISEASE PROGRESSION 909
1.9%
23 NEUTROPHIL COUNT DECREASED 885
1.9%
24 RASH 883
1.9%
25 MUCOSAL INFLAMMATION 831
1.7%
26 PAIN 828
1.7%
27 HYPOTENSION 773
1.6%
28 ABDOMINAL PAIN 771
1.6%
29 DECREASED APPETITE 743
1.6%
30 BACK PAIN 737
1.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.